Orange Book product · Brand (NDA)
SITAVIG
ACYCLOVIR
At a glance
Apr 12, 2013
Approved
Brand (NDA)
Application
Not listed
TE code
3
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Apr 12, 2013
13 yr 5 mo ago
Today
Patent 8791127 expires
Listed drug product patent expiration.
Mar 23, 2027
in 9 mo
Patent 8747896 expires
Listed drug product patent expiration.
Jun 03, 2027
in 1 yr
Patent 8592434 expires
Listed drug product patent expiration.
Jun 16, 2030
in 4 yr 1 mo
Pharmaceutical detail
Active ingredient
ACYCLOVIR
Strength
50MG
Dosage form
TABLET
Route
BUCCAL
TE code
Not listed
Application
NDA 203791
Product number
001
Marketing status
DISCN
Reference listed drug (RLD)
Yes
Reference standard (RS)
No
Active-ingredient family
View full familyThis is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.
- 2019AVACLYRBrand (NDA)
NDA 202408 · FERA PHARMS LLC
- 2002ZOVIRAXBrand (NDA)
NDA 021478 · BAUSCH
- 1985ZOVIRAXBrand (NDA)
NDA 018828 · PHARMOBEDIENT
- 1982ZOVIRAXBrand (NDA)
NDA 018604 · BAUSCH
- 2025ACYCLOVIRGeneric (ANDA)
ANDA 212981 · CIPLA
- 2024ACYCLOVIRGeneric (ANDA)
ANDA 205470 · SUN PHARMA CANADA
- 2023ACYCLOVIRGeneric (ANDA)
ANDA 212361 · ALEMBIC
- 2023ACYCLOVIRGeneric (ANDA)
ANDA 206770 · ZYDUS LIFESCIENCES
- 2022ACYCLOVIRGeneric (ANDA)
ANDA 216331 · AUROBINDO PHARMA
- 2021ACYCLOVIRGeneric (ANDA)
ANDA 212202 · PRINSTON INC
- 2021ACYCLOVIRGeneric (ANDA)
ANDA 212444 · MACLEODS PHARMS LTD
- 2020ACYCLOVIRGeneric (ANDA)
ANDA 208766 · AMNEAL
Listed patents (3)
| Patent | Expires | In | Type |
|---|---|---|---|
| 8791127 | Mar 23, 2027 | in 9 mo | ProductU-1460 |
| 8747896 | Jun 03, 2027 | in 1 yr | ProductU-1460 |
| 8592434 | Jun 16, 2030 | in 4 yr 1 mo | ProductU-1460 |

